Technical analysis of Hoth Therapeutics, Inc. (HOTH): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D.
Price Performance
| 1 month | +0.00% |
| 3 months | +0.00% |
| Year-to-date | +71.72% |
| 1 year | -2.86% |
| 3 years | -0.58% |
| 5 years | -94.52% |
52-Week Range
| 52-week High | $2.20 |
| 52-week Low | $0.49 |
| Avg Volume (90d) | 5.0M |
Technical Indicators
| SMA 50 | $0.75 |
| SMA 200 | $1.11 |
| Beta | 0.60 |
| 30-day Volatility (annualised) | 202.6% |
| Price vs SMA 50 | +127.8% |
| Price vs SMA 200 | +52.9% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.42 | |
| 2025-11 | $1.21 | -14.8% |
| 2025-12 | $0.99 | -18.2% |
| 2026-01 | $0.89 | -10.3% |
| 2026-02 | $1.01 | +13.7% |
| 2026-03 | $0.84 | -16.8% |
| 2026-04 | $0.75 | -11.2% |
| 2026-05 | $1.70 | +127.9% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.80 |
| Market Cap | $11M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 2.22 |
| EV / EBITDA | -0.60 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 0.00 |
| Current Ratio | 4.72 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -11.74 |